aXichem obtains new order for aXivite from its U.S. distributor SEE Nutrition

aXichem AB (publ), (aXichem) a pioneer of innovative natural analogue ingredients for the nutraceutical industry, is pleased to announce a significant new order from its U.S. distributor SEE Nutrition. The order, valued at SEK 3 million, is for one metric ton of aXivite a scientifically proven synthetic capsaicin ingredient. SEE Nutrition markets and sells aXivite to suppliers of sports, fitness, pre-workout and weight management nutrition products and supplements in the U.S. Market.

"SEE Nutrition reports robust sales growth of aXivite from both new and existing customers. This order ensures that they can maintain short lead times for their clients. aXivite is gaining considerable attention due to its documented effects on sports performance and training and new consumer products are continuously being developed and tested. I am delighted that SEE Nutrition is proactively positioning aXivite as a safe, effective, and versatile ingredient in this rapidly growing market segment", says Lucas Altepost, VP Sales & Marketing at aXichem.

The global sports nutrition market continues to show robust growth, driven by increasing consumer interest in health, fitness, and performance. According to the Nutrition Business Journal, U.S. sports nutrition and weight management sales are expected to reach $102.32 billion by 2027, up from $69.86 billion in 2023. This growth is largely attributed to the increasing popularity of sports nutrition supplements, protein beverages, and weight management products​​.

About phenylcapsaicin and aXivite
aXichem's proprietary molecule, phenylcapsaicin, combines the naturally occurring phenyl group with capsaicin, connected by a triple bond. The result is an innovative natural analog capsaicin with high purity, which in several studies has been shown to have the same health-promoting properties, as well as some unique benefits, as natural capsaicin. Phenylcapsaicin is approved under Novel Food in the EU and GRAS Food in the USA and is marketed for dietary supplements and functional foods under the brand name aXivite.

The information was submitted, through the care of the contact person below, for publication on 25 June 2024, at 08:30 AM CET.

Company contact:
Torsten Helsing, CEO, aXichem AB
Phone: +46 706 863 355 Email: torsten.helsing@axichem.com

About aXichem
aXichem develops, patents and markets natural analogue industrial chemicals, i.e., synthetically produced substances that have similar and comparable properties to natural substances. The company's first product is phenylcapsaicin, which the company commercializes under two brands, aXiphen® and aXivite®, as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an ingredient in feed for poultry, such as chicken and turkey; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio- enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. Certified advisor for aXichem is Västra Hamnen Corporate Finance AB.

More information is available at www.axichem.com.

Datum 2024-06-25, kl 08:30
Källa Cision
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!